Shenzhen exoskeleton maker Milesun Robotics has closed a new strategic round of nearly RMB 100 million, led by CSC Financial, the state-backed securities arm. The raise accelerates product iteration and the rollout of frontier work such as brain-computer interfaces, while extending the company’s reach from hospital and community into the last mile of home-based care.
Milesun had already drawn a roster of top-tier backers. Lenovo Capital backed it across four consecutive rounds, joined by Taiyou Fund, Sihuan Pharma, Xingchen Fund, Dening Industrial and Shangshan Capital. The company said its new CEO, Chen Kangning, spent years inside multinationals such as Johnson & Johnson and brings end-to-end experience in product registration and channel building.
Founded in 2016 by a team of returned PhDs, Milesun builds medical and elder-care exoskeleton products. Its portfolio spans the H, A and C (paediatric lower-limb rehabilitation) series, a 3,000-step wellness line and a daily walking-assist MAX line, covering in-hospital rehab, home care and everyday mobility.
From niche gadget to care necessity
Milesun holds more than 200 patents, and its core products have cleared China’s NMPA Class II medical-device certification and entered the market at volume. In 2025 its revenue grew close to 200 per cent, with overseas sales contributing more than a third. The wider market is moving fast: IDC estimates China’s exoskeleton market passed RMB 1.6 billion in 2025 with shipments of about 26,000 units, medical rehab leading on value while consumer-assist devices drove over 70 per cent of volume.
The momentum is accelerating into 2026. Ministry of Commerce data shows domestic smart-exoskeleton demand rose 458.4 per cent year on year in the first half, and JD.com retail records a year-on-year sales jump above 15,000 per cent. Policy is leaning in too: the National Healthcare Security Administration’s 15th Five-Year plan explicitly promotes smart exoskeletons in long-term care. With policy, market and consumer tailwinds stacked, exoskeletons are shifting from black-tech curiosity to a care necessity.
Editor’s note: This is an adapted translation of the original OFweek Robot report. It has been trimmed and restructured for readability for an international business audience.
Translated and adapted from OFweek Robot (https://robot.ofweek.com/2026-08/ART-8321203-8120-30700672.html).